Thomson Reuters (NYSE:TRI) Rating Increased to Hold at StockNews.com

StockNews.com upgraded shares of Thomson Reuters (NYSE:TRI) (TSE:TRI) from a sell rating to a hold rating in a research note released on Thursday morning.

Several other analysts also recently issued reports on TRI. Wells Fargo & Company raised their price target on Thomson Reuters from $165.00 to $177.00 and gave the stock an “equal weight” rating in a report on Friday, February 7th. CIBC raised their target price on Thomson Reuters from $165.00 to $174.00 in a research note on Friday, February 7th. The Goldman Sachs Group upped their price target on shares of Thomson Reuters from $168.00 to $188.00 and gave the stock a “neutral” rating in a research report on Friday, February 7th. Royal Bank of Canada lifted their price objective on shares of Thomson Reuters from $171.00 to $173.00 and gave the company a “sector perform” rating in a research report on Wednesday, November 6th. Finally, Scotiabank upped their target price on shares of Thomson Reuters from $187.00 to $188.00 and gave the stock a “sector outperform” rating in a research report on Friday, February 7th. Nine equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $182.09.

Thomson Reuters Stock Down 0.5 %

TRI stock opened at $175.08 on Thursday. The firm has a market cap of $78.80 billion, a price-to-earnings ratio of 35.80, a PEG ratio of 5.67 and a beta of 0.73. Thomson Reuters has a 1-year low of $149.50 and a 1-year high of $180.42. The firm has a fifty day moving average price of $168.17 and a two-hundred day moving average price of $167.50. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.02 and a quick ratio of 0.94.

Thomson Reuters (NYSE:TRI) (TSE:TRI) last announced its quarterly earnings data on Thursday, February 6th. The business services provider reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.97 by $0.04. Thomson Reuters had a net margin of 30.45% and a return on equity of 14.62%. Research analysts predict that Thomson Reuters will post 3.89 EPS for the current year.

Thomson Reuters Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 10th. Investors of record on Thursday, February 20th will be issued a dividend of $0.595 per share. This is a boost from Thomson Reuters’s previous quarterly dividend of $0.54. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.38 annualized dividend and a yield of 1.36%. Thomson Reuters’s payout ratio is presently 48.67%.

Hedge Funds Weigh In On Thomson Reuters

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TRI. Decker Retirement Planning Inc. bought a new stake in shares of Thomson Reuters in the 4th quarter worth $26,000. Curio Wealth LLC bought a new stake in Thomson Reuters in the fourth quarter worth about $26,000. SBI Securities Co. Ltd. bought a new stake in Thomson Reuters in the fourth quarter worth about $27,000. Investment Management Corp VA ADV bought a new position in shares of Thomson Reuters during the 4th quarter valued at about $29,000. Finally, Noble Wealth Management PBC bought a new position in shares of Thomson Reuters during the 4th quarter valued at about $33,000. 17.31% of the stock is owned by institutional investors.

About Thomson Reuters

Thomson Reuters Corporation engages in the provision of business information services in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in five segments: Legal Professionals, Corporates, Tax & Accounting Professionals, Reuters News, and Global Print. The Legal Professionals segment offers research and workflow products focusing on legal research and integrated legal workflow solutions that combine content, tools, and analytics to law firms and governments.